Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GNF-2 是一种高选择性的非 ATP 竞争性 Bcr-Abl 抑制剂。 它抑制 Ba/F3.p210 增殖,IC50为 138 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 238 | 现货 | ||
2 mg | ¥ 332 | 现货 | ||
5 mg | ¥ 578 | 现货 | ||
10 mg | ¥ 996 | 现货 | ||
25 mg | ¥ 1,960 | 现货 | ||
50 mg | ¥ 3,670 | 现货 | ||
100 mg | ¥ 5,290 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 638 | 现货 |
产品描述 | GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl. |
靶点活性 | BCR-ABL (K562 cell lines):273 nM, BCR-ABL (SUP-B15 cell lines):268 nM |
体内活性 | 1 μM GNF-2诱导 Ba/F3.p210 细胞和Ba/F3.p210E255V 细胞的凋亡。GNF-2以剂量依赖性方式抑制Bcr-abl的细胞酪氨酸磷酸化,IC5??0为267 nM。1 μM GNF-2诱导Ba/F3.p210细胞中磷酸化Stat5水平的显著降低。10 μM GNF-2需要BCR和/或 c-Abl SH3 和/或 SH2 域抑制BCR-Abl依赖性细胞增殖。10 μM GNF-2以剂量依赖性方式明显抑制CrkII的酪氨酸磷酸化。GNF-2作用于表达 c-AblG2A 的细胞,抑制CrkII 磷酸化,IC50为 0.051 μM。GNF-2抑制表达p210Bcr-Abl和p210Bcr-Abl突变体的BafF3细胞的自体磷酸化和增殖。与GNF-5(20 nM)组合的GNF-2(8 nM)在抑制Abl64-515激酶活性方面产生累加效应。GNF-2抑制Bcr-abl阳性细胞生长,IC50值为273 nM (K562) 和 268 nM (SUP-B15),这种作用具有剂量依赖性。GNF-2抑制Ba/F3.p210E255V Ba/F3.p185Y253H细胞生长,IC50分别为268 nM和194 nM。 |
激酶实验 | Binding assay: Recombinant proteins (100 nM for each construct) or immunoprecipitated proteins are diluted in kinase buffer (20 mM HEPES (pH 7.4), 50 mM KCl, 0.1% CHAPS, 30 mM MgCl2, 2 mM MnCl2, 1 mM DTT, and 1% glycerol). Aliquots of the diluted proteins are preincubated with either DMSO or compounds for 30 min at room temperature and then added to K-LISA PTK EAY reaction plates. The kinase reaction is initiated by adding 0.1 mM ATP and is allowed to proceed for 30 min at room temperature. The phosphorylation of GST-Abltide is monitored by SDS-PAGE and phosphorimaging analysis or autoradiography. |
细胞实验 | Cells (0.3-0.6 × 106 per mL) are plated in duplicate or triplicate in 96-well plates containing increasing GNF-2 concentrations (5 nM–10 μM). After incubation at 37 ℃ in 5% CO2 for 48 hours, the effect of GNF-2 on cell viability is determined by the MTT colorimetric dye reduction method. Inhibition of cell proliferation is calculated as a percentage of growth of DMSO-treated cells, and IC50 values are determined with Microsoft Excel XLfit3.(Only for Reference) |
别名 | GNF2 |
分子量 | 374.32 |
分子式 | C18H13F3N4O2 |
CAS No. | 778270-11-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 37.4 mg/mL (100 mM)
Ethanol: 18.7 mg/mL (50 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.6715 mL | 13.3576 mL | 26.7151 mL | 66.7878 mL |
5 mM | 0.5343 mL | 2.6715 mL | 5.343 mL | 13.3576 mL | |
10 mM | 0.2672 mL | 1.3358 mL | 2.6715 mL | 6.6788 mL | |
20 mM | 0.1336 mL | 0.6679 mL | 1.3358 mL | 3.3394 mL | |
50 mM | 0.0534 mL | 0.2672 mL | 0.5343 mL | 1.3358 mL | |
DMSO | 100 mM | 0.0267 mL | 0.1336 mL | 0.2672 mL | 0.6679 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GNF-2 778270-11-4 Angiogenesis Cytoskeletal Signaling Microbiology/Virology Tyrosine Kinase/Adaptors Bcr-Abl SARS-CoV SARS coronavirus allosteric non-ATP competitive inhibitor Ba/F3.p185Y253H Ba/F3.p210E255V Ba/F3.p210 bone erosion Inhibitor GNF2 GNF 2 inhibit inhibitor